Javascript must be enabled to continue!
Myocardial telocytes: a specific new cellular entity
View through CrossRef
Abstract
Introduction
Cellular compartments of telocytes
Distribution of telocytes in the heart
Possible functions of telocytes in the myocardium
Telocytes and myocardial remodelling
Unresolved issues regarding myocardial telocytes
The existence of a new type of interstitial cells in the heart namely, interstitial Cajal‐like cells (ICLC), has been described for the first time by Hinescu and Popescu in 2005. This study was then followed by an ascending trend of publications regarding the morphology, phenotype and distribution of myocardial ICLC in diverse species including human patients. Recently the new term ‘telocytes’ has been proposed for cells formerly known as ICLC, and the term ‘telopodes’ has been proposed for the prolongations of these cells. The identification of these cells is based on ultrastructural criteria. In addition, telocyters/telyopodes can be identified by several complementary approaches including methylene blue vital staining, silver impregnation and immunoreactivity against CD117/c‐kit, vimentin, etc. This point of view presents critical data existing in literature, as well as own results, which unequivocally provide compelling evidence that telocytes are a new distinct cellular entity of myocardial interstitium. Several presumable functions of the myocardial telocytes are discussed: (i) intercellular signalling, (ii) cardiac repair/remodelling and (iii) stem cell nursing in cardiac renewal.
Title: Myocardial telocytes: a specific new cellular entity
Description:
Abstract
Introduction
Cellular compartments of telocytes
Distribution of telocytes in the heart
Possible functions of telocytes in the myocardium
Telocytes and myocardial remodelling
Unresolved issues regarding myocardial telocytes
The existence of a new type of interstitial cells in the heart namely, interstitial Cajal‐like cells (ICLC), has been described for the first time by Hinescu and Popescu in 2005.
This study was then followed by an ascending trend of publications regarding the morphology, phenotype and distribution of myocardial ICLC in diverse species including human patients.
Recently the new term ‘telocytes’ has been proposed for cells formerly known as ICLC, and the term ‘telopodes’ has been proposed for the prolongations of these cells.
The identification of these cells is based on ultrastructural criteria.
In addition, telocyters/telyopodes can be identified by several complementary approaches including methylene blue vital staining, silver impregnation and immunoreactivity against CD117/c‐kit, vimentin, etc.
This point of view presents critical data existing in literature, as well as own results, which unequivocally provide compelling evidence that telocytes are a new distinct cellular entity of myocardial interstitium.
Several presumable functions of the myocardial telocytes are discussed: (i) intercellular signalling, (ii) cardiac repair/remodelling and (iii) stem cell nursing in cardiac renewal.
Related Results
Changes in the ultrastructure of cardiac telocytes during early postnatal development of the myocardium of Wistar rats
Changes in the ultrastructure of cardiac telocytes during early postnatal development of the myocardium of Wistar rats
Relevance. In 2010, the term "telocyte" was introduced into foreign scientific morphological literature to describe a new type of cell that is part of the connective tissue compone...
Morphological Alternations of Intraepithelial and Stromal Telocytes in Response to Salinity Challenges
Morphological Alternations of Intraepithelial and Stromal Telocytes in Response to Salinity Challenges
Summary statement
The article represent an experimental study in which we investigated the effect of the ssalinty on the communicating cells (telocytes) and their...
Participation of cardiac thelocytes in the formation and protection of myocardial blood microscope in the process of early postnatal development of Wistar rats
Participation of cardiac thelocytes in the formation and protection of myocardial blood microscope in the process of early postnatal development of Wistar rats
Relevance. In recent years, active studies of the participation of telocytes in prenatal and postnatal angiogenesis of mammals have been observed. Despite certain successes in stud...
Telocytes regulate macrophages in periodontal disease
Telocytes regulate macrophages in periodontal disease
Telocytes (TCs) or interstitial cells are characterised in vivo by their long projections that contact other cell types. Although telocytes can be found in many different tissues i...
Telocytes contribute to aging-related modifications in the prostate
Telocytes contribute to aging-related modifications in the prostate
AbstractTelocytes are interstitial cells present in the stroma of several organs, including the prostate. There is evidence that these cells are present during prostate alveologene...
Simulation and Modeling of Telocytes Behavior in Signaling and Intercellular Communication Processes
Simulation and Modeling of Telocytes Behavior in Signaling and Intercellular Communication Processes
Background: Telocytes (TCs) are unique interstitial or stromal cells of mesodermal origin, defined by long cellular extensions called telopodes (Tps) which form a network, connecti...
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Abstract
Introduction
The short half-life of standard factor VIII (FVIII) products means that frequent injections (3 to 4 times/week) are needed for e...
A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF): Identification Of The Recommended Phase 2 Dose
A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF): Identification Of The Recommended Phase 2 Dose
Abstract
Background
Myelofibrosis (MF) is a myeloproliferative neoplasm associated with progressive, debilitating symptoms that ...

